IDH2 and cancer: As ascorbic acid availability is lowered by the altered NADP+/NADPH ratios in IDH mutant cancers [64], it should also be noted that ascorbate encourages hydroxylase activity to suppress the transcriptional response of HIF-1α [72,73].